The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species.
作者信息
Schumacher H, Smith R L, Williams R T
出版信息
Br J Pharmacol Chemother. 1965 Oct;25(2):338-51. doi: 10.1111/j.1476-5381.1965.tb02054.x.
Abstract
摘要
相似文献
1
The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species.沙利度胺的代谢：沙利度胺及其某些水解产物在不同物种中的命运。
Br J Pharmacol Chemother. 1965 Oct;25(2):338-51. doi: 10.1111/j.1476-5381.1965.tb02054.x.
2
The metabolism of thalidomide: some biological effects of thalidomide and its metabolites.沙利度胺的代谢：沙利度胺及其代谢产物的一些生物学效应。
Br J Pharmacol Chemother. 1965 Oct;25(2):352-62. doi: 10.1111/j.1476-5381.1965.tb02055.x.
3
The fate of the hydrolysis products of thalidomide in the pregnant rabbit.沙利度胺水解产物在怀孕兔子体内的命运。
Biochem J. 1967 Aug;104(2):570-4. doi: 10.1042/bj1040570.
4
The metabolism of thalidomide: the spontaneous hydrolysis of thalidomide in solution.沙利度胺的代谢：沙利度胺在溶液中的自发水解。
Br J Pharmacol Chemother. 1965 Oct;25(2):324-37. doi: 10.1111/j.1476-5381.1965.tb02053.x.
5
Relationship between teratogeny and structure in the thalidomide field.沙利度胺领域中致畸性与结构的关系。
Experientia. 1968 Oct 15;24(10):993-4. doi: 10.1007/BF02138700.
6
7
The fate of[14C]thalidomide in the pregnant rabbit.[14C]沙利度胺在妊娠兔体内的转归
Biochem J. 1967 Aug;104(2):565-9. doi: 10.1042/bj1040565.
8
Metabolism of thalidomide in Pseudomonas aeruginosa NCTC A 7244.沙利度胺在铜绿假单胞菌NCTC A 7244中的代谢
Acta Pathol Microbiol Scand B Microbiol Immunol. 1970;78(4):488-94. doi: 10.1111/j.1699-0463.1970.tb04332.x.
9
Thalidomide. A study of biochemical teratology.
Arch Environ Health. 1968 Apr;16(4):493-502. doi: 10.1080/00039896.1968.10665097.
10
Thalidomide: disposition in rhesus monkey and studies of its hydrolysis in tissues of this and other species.沙利度胺：在恒河猴体内的处置及其在该物种和其他物种组织中的水解研究。
J Pharmacol Exp Ther. 1970 Jun;173(2):265-9.
引用本文的文献
1
Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs.基于 Cereblon 的 PROTAC 的合成、生物学评价及临床试验
Commun Chem. 2025 Jul 29;8(1):218. doi: 10.1038/s42004-025-01598-9.
2
Thalidomide-induced limb malformations: an update and reevaluation.沙利度胺所致肢体畸形：最新进展与重新评估
Arch Toxicol. 2025 May;99(5):1643-1747. doi: 10.1007/s00204-024-03930-z. Epub 2025 Apr 8.
3
Diversity Synthesis Using Glutarimides as Rhodium Carbene Precursors in Enantioselective C-H Functionalization and Cyclopropanation.在对映选择性C-H官能化和环丙烷化反应中使用戊二酰亚胺作为铑卡宾前体的多样性合成
J Am Chem Soc. 2025 Apr 2;147(13):11336-11345. doi: 10.1021/jacs.5c00568. Epub 2025 Mar 18.
4
Ni-Catalyzed Asymmetric Reductive Arylation of α-Substituted Imides.镍催化α-取代酰亚胺的不对称还原芳基化反应
J Am Chem Soc. 2024 Oct 30;146(43):29523-29530. doi: 10.1021/jacs.4c09327. Epub 2024 Oct 16.
5
Asymmetric Dirhodium-Catalyzed Modification of Immunomodulatory Imide Drugs and Their Biological Assessment.不对称铑催化的免疫调节酰亚胺药物修饰及其生物学评估。
ACS Med Chem Lett. 2024 Aug 23;15(9):1575-1583. doi: 10.1021/acsmedchemlett.4c00297. eCollection 2024 Sep 12.
6
Anhydrous and Stereoretentive Fluoride-Enhanced Suzuki-Miyaura Coupling of Immunomodulatory Imide Drug Derivatives.无水立体保留氟化物增强的免疫调节亚胺药物衍生物的铃木-宫浦偶联反应。
J Org Chem. 2024 Apr 5;89(7):4595-4606. doi: 10.1021/acs.joc.3c02873. Epub 2024 Mar 7.
7
Anti-emetic effects of thalidomide: Evidence, mechanism of action, and future directions.沙利度胺的止吐作用：证据、作用机制及未来方向。
Curr Res Pharmacol Drug Discov. 2022 Oct 27;3:100138. doi: 10.1016/j.crphar.2022.100138. eCollection 2022.
8
Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs.苯并戊二酰胺：设计 PROTAC 的替代 cereblon 配体。
Angew Chem Int Ed Engl. 2021 Dec 13;60(51):26663-26670. doi: 10.1002/anie.202108848. Epub 2021 Nov 16.
9
Novel advances in biotransformation and bioactivation research - 2020 year in review.生物转化和生物活化研究的新进展——2020 年回顾。
Drug Metab Rev. 2021 Aug;53(3):384-433. doi: 10.1080/03602532.2021.1916028. Epub 2021 Jun 24.
10
A history of the roles of cytochrome P450 enzymes in the toxicity of drugs.细胞色素P450酶在药物毒性中作用的历史。
Toxicol Res. 2020 Aug 18;37(1):1-23. doi: 10.1007/s43188-020-00056-z. eCollection 2021 Jan.
本文引用的文献
1
Teratogenic effects of thalidomide and related substances.沙利度胺及相关物质的致畸作用。
Lancet. 1963 Mar 9;1(7280):552. doi: 10.1016/s0140-6736(63)91346-1.
2
[On the behavior of thalidomide in the organism. 1].
Arzneimittelforschung. 1962 Nov;12:1095-8.
3
Phthaloylisoglutamine, a metabolite of thalidomide.邻苯二甲酰异谷氨酰胺，一种沙利度胺的代谢产物。
Life Sci (1962). 1962 Jul;1:333-6. doi: 10.1016/0024-3205(62)90128-5.
4
Enzymatic metabolism of drugs and other foreign compounds.药物及其他外来化合物的酶促代谢
Annu Rev Biochem. 1958;27(3):427-54. doi: 10.1146/annurev.bi.27.070158.002235.
5
Some physico-chemical factors in drug action.药物作用中的一些物理化学因素。
J Pharm Pharmacol. 1957 Jun;9(6):345-80. doi: 10.1111/j.2042-7158.1957.tb12289.x.
6
The metabolism of thalidomide: the spontaneous hydrolysis of thalidomide in solution.沙利度胺的代谢：沙利度胺在溶液中的自发水解。
Br J Pharmacol Chemother. 1965 Oct;25(2):324-37. doi: 10.1111/j.1476-5381.1965.tb02053.x.
Zotero 插件